Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-10 12:00 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Medicxi Growth I LP | 2,067,861 8.4% | 2,067,861 (New Position) | View |
| 2020-01-27 06:03 am Unchanged | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 8,672,000 27% | 0 (Unchanged) | View |
| 2019-11-08 5:26 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | RA CAPITAL MANAGEMENT L.P. | 3,646,646 12.6% | 3,646,646 (New Position) | View |
| 2019-11-06 1:50 pm Purchase | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | Frazier Life Sciences IX L.P. | 7,284,269 25.1% | 7,284,269 (New Position) | View |
| 2019-11-06 06:08 am Purchase | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 8,672,000 24.7% | 8,672,000 (New Position) | View |